Our late breaking abstract portal will be accepting submissions on January 11 - February 25
Late Breaking Abstract Submission Guidelines
Our late breaking abstract portal will be accepting submissions on January 11 - February 25.
Authors may submit late breaking abstracts on the following topics in neuromuscular disease (NMD) research and care:
- Pre-Clinical Research
- Translational Research
- Clinical Trials
- Clinical Management
Late breaking abstract submissions can be considered for oral presentations and have the ability to present any groundbreaking research on Thursday, March 18, 2021 as part of the 2021 MDA Virtual Clinical & Scientific Conference.
Those not selected for oral presentations will have the option of being presented as part of the virtual poster session.
Late-breaking abstracts must not be a revision of an abstract submitted prior to the original submission deadline. Late-breaking abstracts must not have been presented, accepted for presentation, or published at any other scientific meeting or journal at the time of submission and must contain data that was only made available after the December 31, 2020 abstract submission deadline.
The first author (presenting author) will receive all future correspondence from MDA regarding the abstract.
Abstract titles should be 150 characters including spaces. Abstract body should not exceed 300 words
Poster Session Guidelines
Final submission can be via one-page PDF of your data. The PDF should be less than or equal to 10 MB max.
All submissions must include the first name, last name, and email address of the author best suited to answer questions.
QR codes may be included as part of your poster to direct viewers to a download of your poster.
Final submission deadlines, PDF specifications and the submission process will be announced shortly
MDA 2021 Embargo Policy
The embargo on all abstracts accepted for the 2021 MDA Virtual Clinical & Scientific Conference lifts on the date and time the abstract is publicly released by MDA.
While authors may publish that their poster has been selected for inclusion in the conference program, data from the final poster presentation may not be shared in any form (print, broadcast or online publication, media release or conference presentation) prior to its official presentation at MDA 2021. Authors retains copyright of his or her abstract and poster.
Encores are permitted provided that: (i) copyright requirements from the initial conference are respected and (ii) prior presentations are disclosed.
For questions about the late breaking abstract submission process or poster session guidelines, please contact Nicole Camacho at email@example.com.